NCT03990103 2019-06-19S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant AscitesChina Medical University, ChinaPhase 2 Unknown66 enrolled